logo

For the Inventor, By the Inventor

Buenos Aires, Argentina

Gador S.a.


USPTO Granted Patents = 11

% Expired Patents = 45.5



Trademarks = 2

Forward Citations = 27

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Rafael Alberto Labriola (5 out of 6 patents)

silverMedal Dora Graciela Tombari (5 out of 5 patents)

bronzeMedal Socrates Papapoulos (4 out of 4 patents)

4.  Adriana Vechhioli (3 out of 3 patents)

5.  Emilio J A Roldan (3 out of 4 patents)

6.  Adriana Vecchioli (3 out of 3 patents)

7.  Daniel Zanetti (2 out of 2 patents)

8.  Damian Cairatti (2 out of 2 patents)

9.  Enrique Piccinni (2 out of 2 patents)

10.  Emilio Ja Roldan (2 out of 2 patents)

11.  Ermond Reijer Van Beek (1 out of 4 patents)

12.  Constanza Pia Mangone (1 out of 1 patent)

13.  Maria Beatriz Garcia (1 out of 1 patent)

14.  Anibal Perez-Lloret (1 out of 2 patents)

15.  Anibal Perez Lloret (1 out of 1 patent)


11 patents:

1. 8952172 - Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it (2015-02-10),
2. 8853187 - Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof (2014-10-07),
3. 8338619 - Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it (2012-12-25),
4. 8153648 - Solid and crystalline dutasteride and processes for preparation thereof (2012-04-10),
5. 7846474 - Use of bisphosphonates for the treatment of osteogenesis imperfecta (2010-12-07),
6. 7560490 - Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof (2009-07-14),
7. 7345183 - Process for obtaining norelgestromin in different relations of isomers E and Z (2008-03-18),
8. 6864228 - Use of bisphosphonates for the treatment of osteogenesis imperfecta (2005-03-08),
9. 6476223 - Method for obtaining N-[3(3-cyano-pyrazole[1,5-a]pyrimidine-7-yl)phenyl]-N-ethyl-acetamide (2002-11-05),
10. 5990098 - Therapeutic use of (1999-11-23),
11. 5885973 - Bone mass anabolic composition comprising olpadronate (1999-03-23),
Company Overview
Gador S.A. is a prominent Argentine pharmaceutical company based in Buenos Aires, specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company focuses on various therapeutic areas, including analgesics, antibiotics, and cardiovascular medications. Gador is committed to innovation and quality, leveraging advanced research and technology to enhance healthcare solutions in Argentina and beyond, while adhering to stringent regulatory standards.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#7 in Buenos Aires

#9 in Argentina

#51,761 in the World

Buenos Aires, AR
Buenos Aires, Argentina

Gador S.a.

Forward Citations = 27

18 inventors:

goldMedal Rafael Alberto Labriola (5 out of 6 patents)

silverMedal Dora Graciela Tombari (5 out of 5 patents)

bronzeMedal Socrates Papapoulos (4 out of 4 patents)

4.  Adriana Vechhioli (3 out of 3 patents)

5.  Emilio J A Roldan (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gador S.a.. Retrieved from https://idiyas.com/company/gador-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…